RESPIRATORY RHYTHMOGENESIS is a complex physiological process and is abnormal in a number of clinical disorders, including RETT syndrome, stroke, Shy-Drager syndrome, and sleep apnea (31) . An inherited basis for respiratory instability is shown from studies in humans and genetically engineered mice (10) ; however, physical demonstration of naturally occurring genetic variations has been elusive (31) . The C57BL/6J (B6) strain of mice exhibits spontaneous pauses (25, 32) and posthypoxic recurrent apneas, whereas the A/J strain of mice do not (12) , indicating an inherent resistance to respiratory instability in the A/J genome. Furthermore, although in both strains breathing is slowed, apnea length is prolonged in the B6 following administration of an inhibitor of neural nitric oxide synthase, and apnea is not produced by the drug in the A/J strain (23) . Finally, use of buspirone as a 5-HT agonist (29) , inhibitors of hydrogen sulfide production (6) , and acetazolamide (30) reduce or eliminate the apnea in the B6.
Our laboratory previously reported, using mouse chromosomal substitution strains (19) , that post-sigh apneas in the B6 could be reversed by introducing chromosome 1 from the A/J on the B6 background (the C57BL/6J-Chr 1 A/J /NaJ or B6a1 mouse) (32) . The B6a1 strain demonstrated a reduced number of spontaneous pauses and resistance to exhibiting posthypoxic pauses and periodic breathing. This suggests that the B6 genome has biological elements resulting in alterations in ventilatory rate and rhythm.
Such studies in inbred mice address genetic and environmental issues, and in the comparison on the B6 and A/J strain an extraordinary amount of variance in rhythmogenesis can be attributed primarily to genetic variation. This assumption makes quantitative trait loci (QTL) analysis an attractive approach for identifying gene regions and potentially genes within the QTL region regulating physiological traits. In regard to respiratory control, this approach was used to examine differences between strains in hypoxic and hypercapnic ventilatory responses (27) , but no physical evidence was found either in identification of a QTL or in a gene to prove causality and set the stage for translational studies in clinical populations with disturbances in respiratory patterning.
In the present study, the hypothesis is that genes encoding components of the NOS, 5-HT, and/or H2S systems would be implicated in a candidate region on chromosome 1. We identified a QTL using an intercross breeding strategy and confirmed its importance with selective breeding of B6 alleles in this QTL region back on to the B6a1 background to restore the abnormal trait. To address gene or pathway identification, we utilized bioinformatic tools to identify candidate gene(s) within the QTL (26) likely to have amino acid changes between B6 and A/J strains. Gene expression in the medulla and pons from the parental mouse inbred strains was utilized to identify differentially expressed genes in the single-QTL region. With this approach, we demonstrate an ability to locate gene regions that regulate control of respiratory rhythmogenesis in the adult mammal.
METHODS

Animals. C57BL/6J (B6) andC57BL/6J-Chr 1
A/J /NaJ (B6a1) mice were obtained at ϳ6 wk of age from the Jackson Laboratory (Bar Harbor, ME). All purchased animals were housed for at least 1 wk before investigation in the Louis Stokes Cleveland VA Animal Research Facility with food and water ad libitum with a consistent 12:12-h light-dark cycle. Animals were studied at 8 -10 wk. The experimental protocols were approved by the Louis Stokes VA Institutional Animal Care and Use Committee (IACUC).
The F 1 mice were generated both from B6 females mated to B6a1 males as well as from B6 males mated to B6a1 females. These F 1 mice were subsequently intercrossed at random to generate 462 F2 animals, all of which were tested for posthypoxic spontaneous apnea phenotypes. After a preliminary analysis identified a broad but highly significant QTL, a B6a1.B6-(rs30880354-rs6157620) strain was generated from selected F 2 animals and refined using breeding directed by genetic markers.
Measurement of ventilatory behavior. Ventilatory behavior was measured by placing animals in a 600-ml Lucite cylindrical plethysmography chamber, and this apparatus has been described previously (11, 12) . Briefly, we measured breathing data via pressure change across a pressure transducer (Validyne DP45, Validyne Engineering, Northridge, CA), which was also attached to a reference chamber. Gas mixtures of various concentrations of O 2 and N2 were introduced to the chamber (ϳ10 LPM) for 20 s to flush the gas mixture into the chamber and then returned to the low-flow flush. The variations of pressure in the chamber were expressed as voltage swings by the transducer output and were recorded using Lab View 7.1 (National Instruments, Austin, TX). The output was then analyzed and scored using a program custom written for our laboratory (Breath Detect). This program scores each individual breath according to the crest and trough of the transducer's voltage output. Frequency (f) is determined and used as the major metric.
On the day before testing, animals were allowed 60 min to acclimate at normoxia to the testing apparatus. On the day of testing, the animals were allowed to acclimate for 60 min before testing. Following this acclimatization period, 5 min of resting breathing data were recorded. After this, the animals were challenged with 5 min of poikilocapnic hypoxia (8% O 2, bal-N2), followed immediately by 5 min of reoxygenation with 100% O 2. At the conclusion of this protocol, animals were returned to room air.
Breathing analysis. Frequency (f) was measured under normoxic conditions at rest and after reoxygenation (100% O2) recovery from poikilocapnic hypoxia (8% O2, 0% CO2). The number of pauses, not counting post-sigh pauses, in the first 2 min of reoxygenation was counted (spontaneous apnea, defined as cessations of breathing of Ն2.0 respiratory cycles), and the number of pauses in the first 2 min of recovery was the quantitative trait since the majority of events occur in this time period (12) .
Genetic analysis. DNA was isolated from the tail of each F2 mouse. Genotyping was performed after identifying 285 single nucleotide polymorphism (SNP) markers chosen for an ability to distinguish between A/J and B6 alleles on chromosome 1 and creating a custom genotyping panel by the Genomics Core Facility in the Genetics Department at Case Western Reserve University. The physical and genomic positions of the SNPs were obtained from http://cgd.jax.org/ mousemapconverter/, using the new standard genetic map for the laboratory mouse (5) . QTL analysis was performed using the R/qtl software package designed for mapping QTL in experimental crosses. Interval mapping was performed for the number of spontaneous apneas after brief hypoxic exposure. In addition to a single-QTL analysis, which is a standard approach, we performed a two-dimensional, two-QTL scan to allow for the possibility that a second gene locus contributes to the presentation of the observed phenotype value (1, 17, 18, 22) . A full two-QTL model considers the possibility that two genetic loci interact epistatically (i.e., show interaction), whereas an additive two-QTL model considers the possibility that two genetic loci contribute to phenotype independently of one another. Significance thresholds for both two-QTL models were determined by 10,000 permutation tests. Log-likelihood odds ratio (LOD) were calculated for each interval, and the LOD number represents the statistical level of association, with higher values being greater differences among the effects of different alleles.
Bioinformatics approach. Genes listed under the single-QTL were downloaded from www.jax.org. A gene was qualified as candidate if the gene was 1) located under the interval that restored the trait, 2) differed in the haplotype of the parental strains, and 3) carried non-synonymous, protein-coding differences between A/J and B6.
Tissue collection for gene expression. Three animals from each parental strain were chosen on the basis of having a representative posthypoxic ventilatory phenotype. All animals were euthanized via 2 min of exposure to carbon dioxide in a designated necropsy chamber. The animal was decapitated with a guillotine at the cervical-thoracic vertebral junction. The medulla and pons were identified and dissected from one another, informed by the prepontine cistern and transverse pontine vein. Total time of dissection did not exceed 5 min, and samples were immediately labeled and stored in a Ϫ80°C freezer.
mRNA extraction. RNA extraction was performed using the Qiagen (Valencia, CA) RNEasy Mini Kit (catalog no. 74104), following the protocol handbook. The final RNA samples were stored in a Ϫ80°C freezer.
RNA purification, hybridization, and microarray. The extracted total RNA was further purified, and 1 l of each RNA sample was used for quality estimation with Experion (Bio-Rad); the qualified sample with RQI Ն 7.0 was used for Affymetrix Gene Chip Whole Transcript Sense Target Labeling protocol. The labeled cDNA with biotin was hybridized with mouse Gene Expression Array 1.0 array.
Data analysis: robust multichip analysis, Bayesian analysis of microarray data, and quantitative real-time RT-PCR.
In compliance with MIAME standards, Affymetrix data files (CHP and CEL) have been deposited in the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus repository. Raw Affymetrix data files (CEL) were imported into Affymetrix Expression Console (EC), and a robust multichip analysis (RMA) was performed (14) . A variety of assessments for quality and variability of intensity were performed using the EC platform. Chip intensity data files were then exported as text files (TXT) from EC and imported as TXT into the Bayesian analysis of microarray (BAM) statistical package (14) . BAM performed the following comparative analyses: 1) B6a1 medulla vs. B6 medulla and 2) B6a1 pons vs. B6 pons. BAM determined both the fold changes between each comparison for each gene and performed a diagnostic analysis for false discovery rate. All differentially expressed genes identified herein met the following two criteria: 1) numerical fold change was found to be Ͼ2, and 2) false detection rate was found to be Ͻ0.01.
After total RNA extraction, real-time PCR (qRT-PCR) was carried out with a 7900HT RT-PCR system (Applied Biosystems, Foster City, CA). The PCR primers and TaqMan MGB probe (FAM dye-labeled) used in the detection and quantification of gene sequences were obtained in an assays-on-demand gene expression kit (Applied Biosystems, p/n 4331182). The Taqman Universal PCR master mix (Applied Biosystems, p/n 4304437) was run in accordance with the protocol accompanying the kit. The thermal cycling conditions include 25°C for 10 min, followed by 37°C for 120 min, and finally 4°C. Three endogenous controls were selected: mouse ACTB (beta actin), mouse GAPDH (glyceraldehyde-3-phosphate dehydrogenase), and mouse TBP (TATA box binding protein). SDS 2.3 software package was utilized for data analysis.
Proteomics for apo a2 peptides. The presence and levels of apoa2 peptide in the brain stem was detected via multiple-reaction monitoring (MRM) analysis using a selected peptide for lysates of brain stem vs. liver tissue using standard proteomic approaches (20, 24) . Initial data-dependent discovery was based on data from Peptide Atlas (http://www.peptideatlas.org/), where apo a2 peptides were reported from the liver (8). Since there was no report of peptide fragments in brain or neural tissues, THEQLTPLVR was selected since it has been detected in a variety of human non-brain tissues such as the liver. An in silica digest of this proposed target was identified using Pinpoint software by ThermoFinnigan (San Jose, CA). Standard peptide was ordered and purchased from New England Peptide (Gardner, MA). A standard peptide concentration curve range from 0.10 fmole/l to 50 fmole/l was generated using 5 pmol/l glucagon in 0.1% formic acid as solvent.
Sample preparation from brain (medulla and pons) and liver samples and optimization was established based on results from trial samples. Isolation of the appropriate parent ions was followed by fragmentation, which produces the transition(s). A total of four transitions was monitored for targeting protein peptide THEQLT-PLVR in brain and liver tissues. Linearity was determined for the selected peptide by spiking standard isotopically labeled peptides into an appropriate matrix. Four transitions (597.3 m/z ¡ 484.3 m/z, 597.3 m/z ¡ 698.4 m/z, 597.3 m/z ¡ 826.5 m/z , and 597.3 m/z ¡ 955.5 m/z ) were selected to be monitored and used for peptide quantification. All four SRM transitions for this peptide exhibited linear responses, with R 2 of 0.993, 0.994, 0.990, and 0.993, respectively. The assay limit of detection (LOD) was 50 amole/l. The limit of quantification was 100 amole/l. The apoa2 protein peptide THEQLTPLVR in brain and liver tissue was successfully detected and quantified. The peptide in tissue sample was plotted against the standard curve to determine concentration per 1 l of processed tissue. Absolute quantification of peptide was performed using Thermo Pinpoint software.
RESULTS
Phenotype data. During recovery from hypoxia, spontaneous apneas were present in ventilatory tracings from the B6 or the subcongenic strain, but not the B6a1 parental strain (Fig. 1) . Specifically, in the first 2 min of reoxygenation, all B6 animals (n ϭ 12) displayed irregular breathing (number of apnea ranged from 1-18), as shown in Fig. 2 . In contrast, none of the B6a1 animals (n ϭ 12) exhibited a spontaneous pause. In the F 1 generation, 5 of 24 animals displayed spontaneous apnea (number of apneas ranged from 1 to 5). In the F 2 generation, 198 of 462 animals displayed spontaneous apnea (number of apneas ranged from 1 to 16). The subcongenic B6a1.B6-(rs30880354-rs6157620) animals (n ϭ 15) displayed irregular breathing (number of events ranged from 1 to 5), less than that seen in the B6.
Standard QTL analysis for the number of spontaneous apnea after brief hypoxic exposure. A one-dimensional, single QTL analysis was performed, linking the number of posthypoxic spontaneous apnea among F 2 offspring to mouse chromosome 1. Significance thresholds for this analysis were determined via 100,000 permutation tests. As displayed in Fig. 3 , a highly significant peak LOD score of 6.15 was located at ϳ69.9 cM (marker rs6239070). number of apneas are displayed. There are significant differences among all curves (P Ͻ 0.032), and post hoc analysis revealed that F1 and F2 curves are similar (P ϭ 0.35), but curves for B6a1, B6, and B6a1.B6-(rs30880354-rs6157620) congenic strains are different (P Ͻ 0.04). Fig. 3 . Shown are the results of a single-QTL analysis for pause trait expressed as Յ1 of Ͼ0 in the 2-min reoxygenation period immediately after the hypoxic exposure. Loglikelihood odds ratio (LOD) plots linking pauses to markers mapped to positions on chromosome 1 among F2 offspring. Significance thresholds (Table) were determined by 100,000 permutation test. Peak LOD (6.15) is located at 69.9 cM (marker rs6239070). Dotted vertical lines indicate region introgressed from the B6 onto the B6a1 genetic background to generate the B6a1.B6-(rs30880354-rs6157620) congenic strain.
Two-QTL scan for the number of spontaneous apneas after brief hypoxic exposure. Significance thresholds of 5.00 and 10.00% for the full two-QTL model in which interactions are permitted were found to be LOD values of 6.14 and 5.69, respectively, whereas 5.00 and 10.00% thresholds for the full two-QTL vs. one-QTL were found to be 4.50 and 4.14, respectively. Maximum LOD full score of 11.9 and LOD fullv. single-QTL score of 4.92 identify both 14.3 and 67.0 cM on mouse chromosome 1 as loci of interest. Bioinformatics. In this QTL region (rs30880354-rs6157620), there are estimated to be 431 proteins expressed. In regard to non-synonymous SNPs, those that would confer protein coding differences, there were ϳ80 genes or suspected genes in the introgressed region (see supplemental Table 1 ).
Gene expression. Expression array data identified hundreds of differentially expressed genes across the entire genome as a result of substitution of A/J Chromosome 1onto the B6 background. Table 2 presents the list for numbers of medullary and pontine genes, illustrating the numerical differences in regard to fold change between the B6a1 and the B6. However, in regard to genes that were present in the single QTL region, there were three genes with non-synonymous codon changes and greater than twofold differences in expression. These genes along with confirmatory quantitative PCR (qPCR) expression measurement data are listed in Table 3 .
Proteomic investigation of apoa2 protein in the brain. In all strains, the levels of the apoa2 peptide fragment THEQLTPLVR were several fold greater in the liver samples (as previously known) than in the brain (Table 4 ). In the brain, the values for THEQLTPLVR in medullary samples from the A/J were generally lower than those from the B6 or B6a1; the order might be B6a1 Ͼ B6 Ͼ A/J and does not track with trait expression. Moreover, the trend does not appear to be directly related to the mRNA expression profiles, where the B6 with the pause trait showed a very high expression compared with the B6a1 without the pause trait (see Table 4 ).
DISCUSSION
In this study, we identified a region on mouse chromosome 1 and introgressed B6 alleles onto the B6a1 background to restore the trait of posthypoxic pauses. Hence, we provide physical evidence for genes that confer resistance to, or alternatively promote, posthypoxic apneas and spontaneous pauses at rest. We then utilized bioinformatics to identify genes that potentially could confer the differential response between the two strains. Differential mRNA expression in the pons and medulla between the parental strains highlighted expression differences in three genes within this introgressed region (discussed below), arguably causal to the trait. Using this combination of genomic tools, none of the candidate genes in this region directly relate to known 5-HT, HS, or NOS neurotransmitter receptor proteins or neurotransmittion activation pathways. Another more proximal location on chromosome 1 might also contribute to the number, but not the appearance, of pauses following reoxygenation. Thus, on the basis of this new information, we now suspect the influence of other novel polymorphic genes and pathways, possibly interacting with known 173075936  Sdhc  173568800  Slamf7  174407561  Slamf9  154706566  Smg7  180973992  Smyd3  158371497  Soat1  158200776  Tdrd5  161788479  Tnr  157869448  Tor1aip1  157912175  Tor1aip2  158603717  Tor3a  145607144  Trove2  154233693  Tsen15 "cardiovascular risk" apolipoprotein pathways, to produce this complex trait of unstable breathing. The significance of the single-QTL result was confirmed by recovering the B6 phenotype in the B6a1.B6-(rs30880354-rs6157620) congenic strain. Other studies of ventilatory behavior, carried out in both mice and human models, may give some added confidence that gene(s) in this region contribute to respiratory control. Figure 6 is a rendering of chromosome 1 that illustrates the current published literature on this area. A bar represents the D1Mit14-D1Mit291 region of chromosome 1, a QTL previously significantly linked to variation in hypercapnic hypoxic minute ventilation, tidal volume, and mean inspiratory flow (Fig. 6 in Ref. 27) . In a broad sense, ventilatory traits to hypoxia-reoxygenation are probably best understood in regard to the relevance of loop-gain and its role in predisposing one to recurrent sleep apnea (28) . The model of recurrent apneas in the B6 is one of abnormal patterning and recurrent apneas, and as a trait potentially relevant to apneas during sleep in adults and neonates or in conditions of inherited or acquired neurological disease (31) .
In the single-QTL and in the introgressed region, there is present C-reactive protein (CRP). Plausibility is based on a common risk for and interactions among human sleep apnea and cardiovascular disease, particularly in Caucasians, and its presence under a QTL in a genome-wide association study of obstructive sleep apnea linked to the trait of apnea-hypopnea index (15) . In existing databases, there are noted 13 informative SNPs present in the B6 and B6a1 CRP gene, but we did not find recurrent posthypoxic apneas to link with expression differences in CRP. This does not negate the potential importance for CRP in the expression of sleep apnea or respiratory control but does lead one away from the CRP gene and protein as a principal target in the present report. Although specific interpretations regarding the significance of these overlapping observations would be purely speculative, the alignment with CRP and with the linkage in the prior report (27) increases the confidence that this is a region in which gene(s) contributing to the dynamic elements of respiratory control and/or for the consequences of sleep disordered breathing might reside.
We used traditional and expanded QTL models for linkage. Since power is diminished by adding a dimension, our use of a two-QTL model is meaningful only if it demonstrates an improvement over all single-QTL models, and it did. In the expanded analyses, there are clues to the existence of three smaller regions on chromosome 1 that might contribute to the trait. Further details as to the number and identification of specific genes is, however, limited. Phenotypically, the difference in the number, but not the appearance, of posthypoxic pauses between the B6 and the subcongenic strain (see Fig. 2 ) suggests that the more proximal QTL outside the introgressed region is not required for the presence of a pause but contributes to the number of posthypoxic pauses. This proximal region is near a second possible, but not significant, QTL region for O 2 /CO 2 interactions, as described by Tankersley and Broman in a B6/C3H/HeJ intercross (Fig. 6 in Ref. 27 ).
In the medulla, there was a limited number of differentially expressed genes encoded on chromosome 1 and containing nonsynonymous SNPs between the B6 and A/J strains. None are linked directly, i.e., within one degree of freedom, to suspected targets (buspirone, acetazolamide, or hydrogen sulfide inhibitors), which we and others have shown to mitigate posthypoxic pauses in the B6. In regard to NOS, one gene residing in the introgressed region, i.e., NOS interactive protein, fails to show expression differences. As for the differentially expressed non-synonymous candidates, none are known to operate directly in ventilatory control. Apoa2 is the second most abundant protein in HDL; overexpression in the mouse results in amyloidosis in liver, heart, and tongue (9) ; and in humans, polymorphisms in Apoa2 have been associated with increased body mass index and insulin resistance (4), factors associated with the appearance of obstructive sleep apnea/hypopnea. Polymorphisms of the SDHC gene appear in the human population, associated with multiple endocrine neoplasia syndromes, pheochromocytomas, and paragangliomas in humans (21); the gene is also known to increase expression with intracellular oxidative stress resulting in apoptosis (13) , and therefore it is considered relevant to plasticity in respiratory control (31) . Furthermore, mutations have been found to upregulate HIF-1-alpha expression (3), potentially relevant to hypoxic consequences of sleep-disordered breathing. Found expressed in pons but not in medulla samples, the gene for Cd84 resides in a region on chromosome 1 associated with neural tube defects in the loop-tail mouse (7) . There are, however, no known links between this structural gene and ventilatory responses or sleep-disordered breathing. There is only one previous report in which apoa2 mRNA expression was reported to be weakly present in neurons of the brain (region not specified) from a congenic strain of mice with amyloidogenicapolipoprotein A-II (Apoa2c) on a genetic background of the amyloidosis-resistant SAM-R/1 strain, called the R1.P1-Apoa2c.strain (8) . In this strain, deposition of fibrils occurred only in peripheral tissues. Allen Brain Atlas indicates mRNA expression of apoa2 in the spinal cord but lists as "negative" all others tissues in the brain and brain stem (http://www.brain-map.org/). Thus, if one were to suspect a priori the significance of apoa2 in brain health or disease, or specifically in conferring differences in ventilatory traits among mouse strains, one would not suspect involvement of this gene or its product. One obstacle we encountered was that the commercial antibody currently available did not work in brain tissue, either because antibody was directed at human protein (40% different in amino acid sequences) or the epitopes used for the commercial antibody are not expressed in the brain (2) or because the available antibody is outdated. Thus a proteomic approach was chosen to determine whether the apoa2 mRNA was functional, and the apoa2 fragment THEQLTPLVR was chosen, being expressed at several-fold higher levels in liver, the control tissue. Levels of peptide fragment was easureable in the medulla of all three strains and in some of the pontine samples. This discovery of an apoa2 peptide fragment is a novel finding; however, there was no direct correlation between peptide levels from the brain stem (or liver) samples and the trait of unstable breathing, i.e., the levels in the B6a1 (stable strain) being similar to the B6 (unstable strain). There is precedent for difference in posttranslational modification of proteins that are tissue specific or alternatively mRNA modification of cellular processes (20) . Another limitation of the proteomic approach is that it does not localize the site of apoa2 peptide nor its distribution in or around respiratory neurons in the medulla. Because of this lack of correlation between the apoa2 fragment and trait expression, it may be premature to examine apoa2 mRNA expression as well as peptide properties in a more direct manner for its potential relevance to human sleep apnea, given its clinical correlation to dyslipidemia (16) .
This report for the first time mechanistically links a specific region on chromosome 1 to respiratory rhythmogenesis. Given the prior art with these models in fields of cardiovascular, neurological, rheumatic, and cancer risk, elements found in mammalian models can give insight into the molecular pathways for human diseases characterized by disturbances in ventilatory patterning. 
